Zivo Bioscience Inc (QB) (ZIVO) News

So,

Who offering on the stock so far today. Almost 8K on the best offers.
Dumb

Amigo Mike

More news this morning on how experts questioning the strategy of culling chickens to combat bird flu. It is not working and driving up egg prices. Wouldn’t it be great if we had a CEO who was able to articulate a message and get on podcasts to explain how there is a natural treatment that reduces transmission? Or a CEO who understands the power of social media to reach decision makers especially in this White House? Instead we have a grandpa with a “golden Rolodex” which has gotten zero exposure or funding partners. Time for new leadership who understands how to be a CEO in 2025.

Let’s hope grandpa wakes up and tells shareholders the plan for Zivo to be a part of this solution. We do not need another missed opportunity like Covid. Find a partner with money and let’s go.

“Agriculture Secretary Brooke Rollins said the plan includes a $500 million investment to strengthen biosecurity measures for farmers, $400 million in aid for those affected by avian flu, and $100 million for research into vaccines and therapeutics for U.S. chicken flocks. It also proposes reviewing and potentially rolling back certain state-level animal welfare regulations the administration considers restrictive.”

A whopping seven shares traded so far. Glad to see the Atlantic City conference was fruitful. Grandpa must have been as articulate as past presentations explain value proposition of investing in Zivo.

Market certainly is not impressed with the geriatric CEO. Handful of shares trading and trending down.

Defensive ?

Hardly. Just the facts. Comparing Zivo to Zoetis in the bird flu lane is just downright dumb.

You are the one throwing around terms like grandpa and geriatric. Ignorant comes to mind.

If ya don't know how long ZIVO been working specifically on coccidiosis .... not my problem. And isn't the right question. The fact is ... at this point in time they have garnered USDA oversight and have done all the necessary testing needed to gain a license with a company that can bring it to market .... all since Payne took over for Dahl. The "geriatric" seems to have a clue and has "attracted the interest of several global animals health companies". Not my words. Payne's words.

The question is whether they monetize it now .... or not ...... and that is all that matters.

Funny you ask me to answer question and you don't answer diddly .... its ok though. I already know the answers to the questions I ask.

Disengaged BoD?? Really ?? How much have you funded ZIVO over the last three years ? Cause they've provided millions in funding. And you have zero idea what they do or dont do for the company.

Amigo Mike

No need to get so defensive. Just answer the question:

How many years are we going on with coccidiosis testing and no revenue generating agreement?

What silly comparison / commentary on bird flu comparing to Zoetis.

Why don't you also add the timeline for Zoetis vaccine development eh ??? Zoetis been working on bird flu vaccines since ...... 2001 ..... and more recently since 2022 for current variant. And is piggybacking on previous approvals. Over 20 YEARS of work

You do realize that FEDERAL AGENCIES HAVE TO PROVIDE THEIR APPROVALS WHICH REQUIRES ALL THE APPROPRIATE TESTING AND MOUNTAINS OF PROOF .... I.E USDA/FDA.

Can you say. Duuuhhhhhhhhhh ???

https://news.zoetis.com/press-releases/press-release-details/2025/Zoetis-Receives-Conditional-License-from-USDA-for-Avian-Influenza-Vaccine-H5N2-Subtype-Killed-Virus/default.aspx

Zivo started in November / December.
Amigo Mike

Zoetis already out with a vaccine for bird flu and communicating with the public and investors while Payne spins in circles with more testing. The geriatric CEO and disengaged board doesn’t move fast enough. How many years are we going on with coccidiosis testing and no revenue generating agreement?

https://amp.cnn.com/cnn/2025/02/16/health/bird-flu-vaccine-zoetis-avian

Curious how you know mgmt is blowing this opportunity. The avian flu opportunity was announced literally just a few weeks ago. And a second trial is already in process.

This stuff doesnt happen overnight. And you've zero idea what this mgmt is or isn't doing with this particular product candidate outside of what has been announced.

What exactly is ZIVO mgmt supposed to be doing according to you ?

Amigo Mike

Rollins, during her confirmation hearing, indicated she’s been in touch with several Republican agriculture commissioners on the situation, which could be among the worst in decades. On Friday, she gave her first comments on the crisis.

"My very first briefing in my office last night was on this particular issue, on the avian bird flu. We are looking at every possible scenario to ensure that we are doing everything we can in a safe, secure manner, but also to ensure that Americans have the food that they need. And as a mom of four teenagers, actually, I fully understand and feel the pain of the cost of these eggs. So we will be announcing more in the coming days," she told reporters.

And we’ll see like 20 shares trade today. Terrible management blowing this opportunity like they did with Covid.

This is interesting....
Brooke Rollins new Agriculture Secretary comment about Bird Flu...
https://www.foxbusiness.com/video/6368840341112

She is making it a top priority

Mike check your email, Tx T.Ks Zivo is very interesting

News reports White House is focused on solutions to mitigate effects of bird flu to bring down price of eggs. Payne needs to step up or step down.

LOL,

You have a company that doesn't know what social media is. Been that way a long time. Don't see it changing under Payne. He's old school. That isn't his style and these guys don't have enough to talk about on a regular basis to keep a social media gig going anyway.

They do seem to find a way to shoot themselves in the foot whenever possible still ...... I don't get it .... like releasing last PR after 430PM on a Thursday evening.

I mean .... LOL .... DUH ..... you sent out a PR I assume you'd want people to read it. Pretty sure you can designate the exact time you want a PR to hit the wires. But everyone's pretty much gone home at 430 except those hanging around for earnings calls this time of year.

Just another reason I lean more each day towards selling the company. ZIVO cannot really "drive" anything the way it is currently set up. I don't see them proving out 1 vertical and then another and another. Too slow. No money. Not enough talent and totally reliant on external partners. The algae and its isolates in the proper hands can drive this thing into multiple verticals much faster than ZIVO. All these major pharmas both human and animal are looking for their next product candidates and ZIVO's got one. $100 is too cheap for buyout for potential verticals in human and animal health but the problem is ZIVO hasn't fully proven anything outside of coccidiosis. I think the Zoetis bovine mastitis tests were positive but I never squeezed out of Dahl why they didn't move forward. If I'm ZIVO and that is in a place that can be brought back to the forefront while "several" animal pharmas are looking .... I'd damn sure be pulling that out of the back room too and calling Kristen Peck ... who I know Payne knows .... and asking "wassup". Chickens, birds, dairy cattle .... all big problems.

Amigo Mike

ZIVO needs to pay someone $100k to just pump out press releases to TV Networks, Newspapers, Bloggers and any other media to let the F##king WORLD know what they got!!!!

The news about poultry is on daily!!!!!
And....no one knows about lil 'ol Zivo

This is now just crazy.......

I wonder who da genius is showing 5000 shares offered at $21.25.

Amigo Mike

Gwinner,

I'm not really surprised ...... ZIVO typically under promises and some day delivers. Timelines are a joke with this company and always have been.

Payne thus far hasn't really offered timelines for things although he did step out and say in the December PR he was expecting to land a license for coccidiosis by the end of the 1st qtr. So that's still 6-7 weeks away. But then there is this presentation given at the MicroCap conference ..... and it sez "1H" ...... i.e. end of June. (slide 14)

IMO ....... there has been some shifting in the timing and language being used. I think Payne offering >>>>>Catalyzed by encouraging findings from completed studies in avian influenza and coccidiosis, ZIVO has attracted interest from several global animal health companies seeking innovative, non-antibiotic solutions to combat disease transmission. This interest underscores the opportunity for ZIVO’s proprietary algal-derived compounds to play a role in improving poultry health and productivity.

Not surprised at all. Payne cannot execute and this board holds no one accountable.

I am truly shocked we don't have the "meaty" news that we all have counted on yet...
The main stream news is flooded with poultry news updates...Come on Zivo ......LETS GOOOOOOOOOOOOOOOOOO!

BlueMax,

Appreciate the note. Sorry to hear you've exited your position and certainly wish you the best with your future investments !

Amigo Mike

Poultry aricle today regarding avian flu.

https://www.wattagnet.com/broilers-turkeys/nutrition-feed/news/15737198/feeding-algae-to-poultry-could-halt-spread-of-low-path-ai
Amigo Mike

Amigo Mike, want to thank you for providing great observations all the time spent on summarizing various PR and other corporate publications. I got to meet Mike at an Annual Investor meeting in Detroit I think in 2013. Also to others who have offered interesting comments. After a very long time associated with ZIVO, going back to HEPI days, I have exited the position. I do hope that the latest information will be very positive for the company and the Investors!

Like I’ve been saying- incompetent investor relations. Why are they paying Tirth?

Interesting info in the PR ....

..... confirmation from Payne Catalyzed by encouraging findings from completed studies in avian influenza and coccidiosis, ZIVO has attracted interest from several global animal health companies seeking innovative, non-antibiotic solutions to combat disease transmission. "SEVERAL" is interesting word.

So in my book, we potentially have an "auction" and "first to act" type scenario here. This note also seems to indicate these companies are interested in both coccidiosis and avian fly applications.

SO BRING IT ON !!!
Amigo Mike

ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry
February 06, 2025 04:36 PM Eastern Standard Time

TROY, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces plans for a second collaborative study with the University of Delaware. This new study aims to further explore the potential applications of ZIVO's proprietary active ingredients in mitigating the spread of Low Pathogenicity Avian Influenza (LPAI) virus among poultry.

ZIVO’s previous study with the University of Delaware demonstrated a significant reduction in viral shedding and a delay in disease transmission among treated birds. This new study is designed to further optimize formulations and treatment protocols with the goal of enhancing the efficacy of ZIVO’s proprietary active ingredients when applied to real-world poultry production environments.

Catalyzed by encouraging findings from completed studies in avian influenza and coccidiosis, ZIVO has attracted interest from several global animal health companies seeking innovative, non-antibiotic solutions to combat disease transmission. This interest underscores the opportunity for ZIVO’s proprietary algal-derived compounds to play a role in improving poultry health and productivity.

"The University of Delaware is a preeminent institution in animal science research and we look forward to continuing our collaboration to advance understanding of how our active ingredients can combat avian influenza," said John Payne, Chairman and CEO of ZIVO Bioscience. "The interest from leading animal health companies further validates our approach and commitment to delivering sustainable, healthier solutions at cost parity to the poultry industry."

“This newest study represents the next step in what we expect will be a series of studies to thoroughly evaluate the potential of ZIVO's products in various avian influenza applications. By leveraging active components from our proprietary algal cultures in new indications, we aim to develop effective, natural alternatives to traditional treatments, thereby addressing the significant challenges in animal health of cost and drug resistance,” added Mr. Payne.

In the category of ..... I JUST DON'T GET IT .... ZIVO releases news starting a new study with the University of Delaware ...... AFTER F*^&ING HOURS ........ I dunno for what purpose.

https://www.businesswire.com/news/home/20250206639313/en/ZIVO-Bioscience-Plans-New-Study-with-University-of-Delaware-to-Combat-Avian-Influenza-in-Poultry

I really just don't get it at all.
Amigo Mike

Mike- I'm still convinced this 'action' we see on most days in ZIVO is one (or two, at most) parties tossing shares back and forth to "paint" the tape/chart the way they want...creating the illusion of demand/selling, etc on any given day.

Volume is just way too low and daily chart is just too perfect looking to be otherwise imo.

I'm still of the opinion, there will be no guessing as to whether something has truly transpired...as we'll see true, real volume coming into the stock.

LOL.

Bid got dumped on while maintaining $22 offer. I guess folks aren't willing to hold on here.

Amigo Mike

It was on the tape (I saw it too), but perhaps a late print from y'day tape...as OTC does not trade a pre and post market...

Looks like new buy interest today as well. Bids moved up to $21.50 area.
But someone standing in the way at $22 .......

Tic toc ..... tic toc .....

Amigo Mike

Did we just have a pre-market trade at 9:08 am ?
Haven't had that in awhile!

Yep..........I'm liking the Bid support the last couple of days...

LOL,

Bid is at $20 this morning. Better than it has been. Size bid of 2000 shares ..... and warrants getting action at higher prices as well.
No real way to know if conference does or doesn't do anything. Ultimately it is about delivery and execution at this point.

ZIVO in talks with at least 1 and maybe 2 global animal pharmas. That in itself IMO warrants at least a $25 stock price based on historical valuation alone and being at the point of generating a license. I think there is more here than meets thr eye .... but I'm just a lone voice in the vast wilderness of the stock market and my own read on ZIVO. Means nothing.

So ... we wait ......

Amigo Mike

UPDATE: Reality of this week...

Nice gobble at 19.50 per share

Bid support strengthens....

I think we can all agree investor relations at Zivo is terrible. Stop wasting money and get rid of them.

Here is Microcap conference powerpoint from ZIVO's website. More in the poor communications dept.

https://d1io3yog0oux5.cloudfront.net/_693ef9cd8614ac34d26b455b76331834/zivobioscience/db/300/1570/pdf/Microcap+2025+Presentation.pdf

Amigo Mike

Gunner,

Honestly I take ZIVO at it's word regarding your quote. Payne clearly is very conservative about what he releases publicly. So "whatever happened to this idea" ..... it should be in motion right now. Tis why I think the action in the stock should be better and frankly still think it should already be above $25.

So at face value ..... we mushrooms should be thinking that ZIVO may be in receipt of a formal licensing offer from a global animal health company by now ... given that tomorrow is the end of January. Whether ZIVO is required to inform investors of receiving a licensing offer ..... I don't think they are obligated to share that unless potentially a specific letter of intent is agreed upon and signed which I think would get PR'd. And unfortunately an LOI is nothing more than 2 companies agreeing to discuss it ... it isn't binding. They of course WOULD be obligated to share if an agreement for a license is actually signed.

But my thinking here is .... lawyers ..... let's say ZIVO does have a licensing offer in hand right now from 1 .. or even more global animal health companies. If more than 1 involved if I am Payne I am not going to take first offer to hit the table. I'm going to play all angles. I don't know if ZIVO has engaged any experts to evaluate the value of a license for poultry and what an appropriate offer should be. Dunno if license request would be for more than poultry as there are closely related species and others that I'm sure are easy to test .... would it be territorial ...... what restrictions if any. My point being ...... I seriously doubt a license deal is offered and signed instantly. Lawyers, fine print, scope, valuation, who pays for what, who gets what .... etc etc etc ...... has to be gone over with fine tooth comb and of course both parties need to come to an agreement. So what I'm getting at is how prepared is ZIVO in understanding what the value of the license is and how long does it take lawyers to fiddle with the language and agree to terms ??? Notice ZIVO said expects to enter formal "negotiations" in January and finalize by EOQ.

So we wait !
Amigo Mike

Expects to enter into formal negotiations with a global animal health company in January 2025 and to finalize an agreement in the first quarter of 2025

Wonder what happened to this idea !!??

Gwinner,

Some bid support remains but doesn't appear to be in any hurry to do anything. And seller backed up a bit ... but still reasonably close on the offer.

As noted the warrants went silent ... but today .... over 43K traded so far. Not sure what to make of that action.
ZIVO about to present in next few minutes at Microcap conference.

Unfortunately I don't have the same positive vibes you do with regard owning the stock and "on the forefront of getting picked up nationally and potentially globally".
There still nobody interested in this stock other than the long time core of investors ....

Does ZIVO get some attention soon ? Dunno ......... I'd sure like to see it. Certainly would like to see PR closing a license with major animal pharma. And certainly would like to see ZIVO associated with avian flu .......... but ........ it's wait and see

Amigo Mike

I liked the BID support today too...hopefully it continues...
However, I have never been so deeply invested into a company that is on the precipice of being in the right spot at the right time. Poultry/Avian all on the news everyday now and ZIVO has been on the forefront of getting picked up nationally and potentially globally. In a racing pole position ZIVO is parked in the right spot.

I would suspect BID support will grow as word gets out about ZIVO. The investor presentations they plan on doing tomorrow will only help spread the word. However, the word just needs to land in the right hands...

Seems we are opening the day with a little bit of interest on the bid in the high $18s this morning ..... a small departure from the recent lower bids and no size being displayed on the offer. Is this the beginning of change in tone ? No one selling into it this morning.

We are reaching the end of January here ..... other than attending Microcap conference and presenting tomorrow afternoon .... some funding news via SEC reporting, not much to speak of. Looks alot like ZIVO spent 4th qtr cleaning it's financial house and setting things in order. They got rid of a small convertible with long time shareholder that used to be huge supporter. In the process of buying out incredibly awful co development participation agreements that partly underscore why Dahl had to go. These were incredibly bad ... last resort financing deals a few years ago .... that would have resulted in ZIVO paying out rouhgly 44% of revenues from licenses to those investors ..... meaning not able to use that revenue to advance business needs.

IMO ZIVO still isn't moving fast enough there and still isn't getting the name out there with what they are doing. I still think $18 is too cheap for where the company supposedly stands ... i.e. on the verge of a license for coccidiosis in chickens with a major animal pharma. But obviously that's just my opinion. Still haven't reached what had been the historical valuation of this company and its further along than ever.

I'd be surprised if the microcap conference stirs any buying. Action in the warrants has disappeared. Myself and everyone else in wait and see mode. I have been considering purchasing some shares .... but have not purchased or sold anything still. My now long term swing is sitting there staring me in the face daily asking me what I'm doing next LOL. Now stagnant for several weeks here. Have basically had too many other swing trade opportunities in other stocks so that's mainly why I have not stepped to the buy window here plus the cost of the trade was recovered long ago as posted here. So riding free.

Gut health and inflammation on the Today Show this AM. LOL

My ZIVO wishlist:
1. Close license for coccidiosis in broiler chickens
1a. Whomever that is ... I'd like to see purchase of stock as part of the deal
2. Quite honestly I'd like to see license or some sort of agreement for the development of coccidiosis candidate for additional verticals (turkey, swine)
3 Get on the stick and bring next round of testing on avian flu. First test was for LPAI ..... I'd like to see something on HPAI. And given the initial results it seems like it is more about tweaking options
4. Funding funding funding ..... for the last year+ basically been insider funding for the most part. See 1a above. Avian Flu is HOT. There are millions and millions of dollars out there being more of less tossed away on non solutions at both state and federal level. ZIVO might just have something that supports and solution ....... they need to find a way to get some of these gov't grants. Unfortunately this is something I think takes a while and I don't think there is a "fast track" path to any of this type money ...... but ZIVO needs to be in the game and making noise here.
5. Sell the company ... I'll take $100+ a share (even though I think it is worth much more). ZIVO given its corporate structure is ripe for sale. A big detractor in my book .... there is no apparent succession plan for Payne. I believe he's in his late 70s. An he's old school. Need to understand the plan and badly needs visibility. Today's electronic age .... ZIVO isn't in the game at all but may have what we all think is a discovery in the inflammation space .... cause that is what all this is rooted in. And I just don't see how this company develops additional verticals and grows without long term leadership. I just don't see years and years more of testing and development of new verticals of which IMO ... there are numerous opportunities with ZIVO's product candidate.

Tic tok .....tic tok ....
Amigo Mike

Looks like ZIVO is presenting at 2:30 PM on Thursday this week.

https://themicrocapconference.com/presentation-schedule/
Not the most ideal presentation time. Still scratching my head a bit regarding why doing this conference and Payne was not good at the last recorded conference.. Also does not appear like there is an option to listen to the conference presentations which doesn't help current investors much. These conferences are usually intended to stir up PP money. If they are discussing license with 1 or more major animal pharmas they should simply be asking them to buy some stock as part of the deal. It's petty cash to them. Don't need scumbag IBs in it. Get a license for coccidosis done and move ahead on avian flu should put stock price back on track towards $25 (and should be higher than that) and additional money can come from warrants that expire in a couple months.

Would be nice if ZIVO had news this week in front of that conference. Something fresh to talk about and get an investor interested.
Amigo Mike

Nice BID support at 17.60 (1,288 shares currently) would like to see that work its way higher throughout the day...
MicroCap Conference is needed...just need to keep spreading the news. Actually i wish they would do 2-3 per month at a minimum

Same as it always was. They cannot execute. No one is putting serious money in this if they cannot pull in revenue. The golden Rolodex is more like fool’s gold.

Just seems to me if they have to keep going to these conferences, looking for investors, no one is interested. What am I missing ?

ZIVO Bioscience to Present at The Microcap Conference 2025
Download as PDFJan 22, 2025
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)-- Zivo Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced its participation in The Microcap Conference 2025 being held January 28-30, 2025, in Atlantic City, N.J.

Management will deliver a corporate presentation and engage in one-on-one meetings with institutional and individual investors to discuss the company’s recent developments, growth strategy, and investment opportunities.

Event: The Microcap Conference 2025
Location: Studio 1, Borgata Hotel Casino & Spa
Date: Thursday January 30, 2025
Time: 2:30 PM Eastern Time

Investors interested in meeting with management can register for the conference here.

About ZIVO Bioscience

Zivo Bioscience, Inc. is a research and development company with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent pending inventions for applications in human and animal health. Please visit www.zivobioscience.com for more information.


View source version on businesswire.com: https://www.businesswire.com/news/home/20250122415215/en/

ZIVO Bioscience
Keith Marchiando, Chief Financial Officer
(248) 452-9866 x130
kmarchiando@zivobioscience.com

Alliance Advisors IR
Tirth T. Patel
(212) 201-6614
tpatel@allianceadvisors.com

Source: Zivo Bioscience, Inc.
Released January 22, 2025